Prospective evaluation of concurrent paclitaxel and radiation therapy after adjuvant doxorubicin and cyclophosphamide chemotherapy for stage II or III breast cancer

Long-term follow-up of patients who received concurrent paclitaxel and radiation therapy after adjuvant doxorubicin and cyclophosphamide chemotherapy for stage II or III breast c

Phase 3 study comparing weekly concomitant boost for breast cancer patients treated with conservative breast surgery with sequential boost

Evaluation of Three Weeks Hypofractionated Whole Breast Irradiation with a Sequential Boost in Breast Cancer Patients

Concurrent Use of Capecitabine with Adjuvant Radiotherapy in the Treatment of Patients with Breast Cancer

Acute and late toxicities of adjuvant hypofractionated radiotherapy with weekly concomitant boost for women with early breast cancer

CONCURRENT CHEMO-RADIOTHERAPY OF WEEKLY PACLITAXEL VERSUS WEEKLY CARBOPLATIN IN LOCALLY ADVANCED HEAD AND NECK CARCINOMAS UNFIT FOR CISPLATIN

Assessment Study in Breast Conservative surgery in Locally Advanced Breast Cancer after Good Response to Neoadjuvant Chemotherapy

RESPONSE OF LOCALY ADVANCED BREAST CANCER TO PRIMARY CHEMOTHERAPY; IS IT ELIGIBLE FOR BREAST CONSERVATION

BREAST-CONSERVING TREATMENT IN PATIENTS WITH LOCALLY ADVANCED BREAST CANCER